AMGN logo Amgen +
Amgen
+

Amgen (AMGN) Business News

Track Amgen in real time with a live news feed covering Amgen stock news, official press releases, company announcements, and an archive of historical Amgen news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
5:45 PM | Friday | Nov 13, 2026 Seeking Alpha

Dividend Champion, Contender, And Challenger Highlights: Week Of November 15

News Thumbnail
5:42 PM | Friday | Nov 13, 2026 The Motley Fool

Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

News Thumbnail
10:06 AM | Wednesday | Nov 11, 2026 Benzinga

Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears

News Thumbnail
9:02 AM | Wednesday | Nov 11, 2026 247 Wallst

Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today

News Thumbnail
8:07 AM | Wednesday | Nov 11, 2026 Reuters

Amgen's experimental Sjogren's drug meets late-stage trial goal

News Thumbnail
8:00 AM | Wednesday | Nov 11, 2026 PRNewsWire

AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE

News Thumbnail
10:06 AM | Wednesday | Nov 11, 2026 Benzinga

Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears

News Thumbnail
9:02 AM | Wednesday | Nov 11, 2026 247 Wallst

Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today

News Thumbnail
8:07 AM | Wednesday | Nov 11, 2026 Reuters

Amgen's experimental Sjogren's drug meets late-stage trial goal

News Thumbnail
8:00 AM | Wednesday | Nov 11, 2026 PRNewsWire

AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE

News Thumbnail
8:47 AM | Tuesday | Nov 10, 2026 24/7 Wall Street

3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them

News Thumbnail
10:01 AM | Monday | Nov 9, 2026 Zacks Investment Research

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

News Thumbnail
9:09 AM | Sunday | Nov 8, 2026 24/7 Wall Street

Amgen's Dividend Has Grown 800% Since 2011. Here's What It Pays Today

News Thumbnail
5:19 AM | Friday | Nov 6, 2026 Defense World

1,809 Amgen Inc. $AMGN Shares Acquired by Alta Advisers Ltd

News Thumbnail
4:27 AM | Friday | Nov 6, 2026 Defense World

Boston Trust Walden Corp Sells 15,695 Shares of Amgen Inc. $AMGN

News Thumbnail
11:05 AM | Thursday | Nov 5, 2026 The Motley Fool

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

News Thumbnail

Dividend Champion, Contender, And Challenger Highlights: Week Of November 15

Seeking Alpha

5:45 PM | Friday | Nov 13, 2026

news photo
Loading...

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Read full article redirect
5:45 PM | Friday | Nov 13, 2026

Dividend Champion, Contender, And Challenger Highlights: Week Of November 15

Seeking Alpha

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Read full article arrow
News Thumbnail
5:42 PM | Friday | Nov 13, 2026

Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

The Motley Fool

Amgen maintains a massive global footprint and a highly diversified portfolio of medicines for serious conditions. Vertex Pharmaceuticals dominates the cystic fibrosis market and is expanding into gene editing and pain management.

Read full article arrow
News Thumbnail
10:06 AM | Wednesday | Nov 11, 2026

Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears

Benzinga

Amgen Inc. (NASDAQ:AMGN) announced positive Phase 3 results showing dazodalibep significantly reduced systemic disease activity and key symptoms in patients with Sjögren's disease, a chronic autoimmune disease in which the immune system mistakenly attacks the body's moisture-producing glands.

Read full article arrow
News Thumbnail
9:02 AM | Wednesday | Nov 11, 2026

Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today

247 Wallst

Selling shares to pay the bills can wreck a retirement portfolio in a downturn. A biotech giant, a Coca-Cola bottler, and a Kansas utility offer another route, though one of them carries a payout ratio above its own target.

Read full article arrow
News Thumbnail
8:07 AM | Wednesday | Nov 11, 2026

Amgen's experimental Sjogren's drug meets late-stage trial goal

Reuters

Amgen's experimental Sjogren's drug meets late-stage trial goal

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Nov 11, 2026

AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE

PRNewsWire

Only Global Phase 3 Trial to Show Clinically Meaningful Improvements in Systemic Disease Activity and Patient-Reported Symptoms of Sjögren's Disease THOUSAND OAKS, Calif., Nov. 11, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced results from the Phase 3 OASIZ-301 study of dazodalibep, the only global Phase 3 trial to demonstrate clinically meaningful improvements in systemic disease activity and symptoms in patients with Sjögren's disease.

Read full article arrow
News Thumbnail
10:06 AM | Wednesday | Nov 11, 2026

Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears

Benzinga

Amgen Inc. (NASDAQ:AMGN) announced positive Phase 3 results showing dazodalibep significantly reduced systemic disease activity and key symptoms in patients with Sjögren's disease, a chronic autoimmune disease in which the immune system mistakenly attacks the body's moisture-producing glands.

Read full article arrow
News Thumbnail
9:02 AM | Wednesday | Nov 11, 2026

Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today

247 Wallst

Selling shares to pay the bills can wreck a retirement portfolio in a downturn. A biotech giant, a Coca-Cola bottler, and a Kansas utility offer another route, though one of them carries a payout ratio above its own target.

Read full article arrow
News Thumbnail
8:07 AM | Wednesday | Nov 11, 2026

Amgen's experimental Sjogren's drug meets late-stage trial goal

Reuters

Amgen's experimental Sjogren's drug meets late-stage trial goal

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Nov 11, 2026

AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE

PRNewsWire

Only Global Phase 3 Trial to Show Clinically Meaningful Improvements in Systemic Disease Activity and Patient-Reported Symptoms of Sjögren's Disease THOUSAND OAKS, Calif., Nov. 11, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced results from the Phase 3 OASIZ-301 study of dazodalibep, the only global Phase 3 trial to demonstrate clinically meaningful improvements in systemic disease activity and symptoms in patients with Sjögren's disease.

Read full article arrow
News Thumbnail
8:47 AM | Tuesday | Nov 10, 2026

3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them

24/7 Wall Street

Biotech usually torches cash and dilutes shareholders to fund the next trial. Three drugmakers flip that script, and the one with the smallest yield may be hiding the sturdiest payout of all.

Read full article arrow
News Thumbnail
10:01 AM | Monday | Nov 9, 2026

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Zacks Investment Research

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read full article arrow
News Thumbnail
9:09 AM | Sunday | Nov 8, 2026

Amgen's Dividend Has Grown 800% Since 2011. Here's What It Pays Today

24/7 Wall Street

Amgen has raised its payout every year since 2011, yet the pace of those raises is cooling just as patent cliffs and drug price controls close in. One number shows whether the next raise, due soon, will hold up.

Read full article arrow
News Thumbnail
5:19 AM | Friday | Nov 6, 2026

1,809 Amgen Inc. $AMGN Shares Acquired by Alta Advisers Ltd

Defense World

Alta Advisers Ltd lifted its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 85.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,919 shares of the medical research company's stock after acquiring an additional 1,809 shares during the

Read full article arrow
News Thumbnail
4:27 AM | Friday | Nov 6, 2026

Boston Trust Walden Corp Sells 15,695 Shares of Amgen Inc. $AMGN

Defense World

Boston Trust Walden Corp trimmed its holdings in Amgen Inc. (NASDAQ: AMGN) by 18.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 67,134 shares of the medical research company's stock after selling 15,695 shares during the period.

Read full article arrow
News Thumbnail
11:05 AM | Thursday | Nov 5, 2026

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

The Motley Fool

Amgen produces strong revenue growth and healthy margins by focusing on complex biological therapies and rare diseases. Pfizer maintains a massive global reach and offers a more conservative balance sheet with a lower valuation profile.

Read full article arrow
News Thumbnail